STEM-ing the progression of Parkinson’s

An exciting new clinical trial called STEM-PD is due to start in Sweden and the UK which will focus on stem cell transplantation as a potential treatment for Parkinson’s.


Results of FAIRPARK-II deferiprone trial published

The results of the most recent study of deferiprone in people with Parkinson’s (the FAIRPARK-II study) have been published in the New England Journal of Medicine. 


The 2022 International Linked Clinical Trials meeting

Cure Parkinson’s annually coordinates the International Linked Clinical Trials (iLCT) meeting to rank and prioritise therapies that may have the potential to modify the course of Parkinson’s progression.


News Research news

2022 Tom Isaacs Award pays tribute to Drs. Michael Okun and Ray Dorsey

Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr Ray Dorsey, University of Rochester, and Dr Michael Okun, University of Florida, are joint winners of the 2022 Tom Isaacs Award.


Phase 1 trial results of new GDNF delivery mechanism

The results of a recent clinical trial testing a new way of delivering the nerve growth factor, GDNF, into the brains of people with Parkinson’s demonstrate that it is safe and well tolerated. Glial cell-line derived neurotrophic factor, or GDNF as it is more commonly…